Canada markets closed

Verona Pharma plc (VRNA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
15.45-0.11 (-0.71%)
At close: 04:00PM EDT
15.42 -0.03 (-0.19%)
After hours: 07:09PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
458
40,000
0
Cost of Revenue
0
0
346
0
-
Gross Profit
0
0
112
40,000
-
Operating Expenses
Research Development
17,216
17,216
49,283
79,406
44,505
Selling General and Administrative
50,353
50,353
26,579
33,907
29,772
Total Operating Expenses
66,465
66,465
66,228
97,683
66,010
Operating Income or Loss
-66,465
-66,465
-66,116
-57,683
-66,010
Interest Expense
2,057
2,057
521
340
35
Total Other Income/Expenses Net
1,866
1,866
-4,632
2,422
924
Income Before Tax
-53,895
-53,895
-68,448
-55,587
-65,000
Income Tax Expense
474
474
253
-18
146
Income from Continuing Operations
-54,369
-54,369
-68,701
-55,569
-65,146
Net Income
-54,369
-54,369
-68,701
-55,569
-65,146
Net Income available to common shareholders
-54,369
-54,369
-68,701
-55,569
-65,146
Basic EPS
-0.56
-0.72
-1.04
-0.96
-2.00
Diluted EPS
-0.56
-0.72
-1.04
-0.96
-2.00
Basic Average Shares
78,105
79,268
66,134
59,149
32,867
Diluted Average Shares
78,105
79,268
66,134
59,149
32,867